263 related articles for article (PubMed ID: 18498250)
1. PRH/Hex: an oligomeric transcription factor and multifunctional regulator of cell fate.
Soufi A; Jayaraman PS
Biochem J; 2008 Jun; 412(3):399-413. PubMed ID: 18498250
[TBL] [Abstract][Full Text] [Related]
2. Oligomerisation of the developmental regulator proline rich homeodomain (PRH/Hex) is mediated by a novel proline-rich dimerisation domain.
Soufi A; Smith C; Clarke AR; Gaston K; Jayaraman PS
J Mol Biol; 2006 May; 358(4):943-62. PubMed ID: 16540119
[TBL] [Abstract][Full Text] [Related]
3. DNA wrapping and distortion by an oligomeric homeodomain protein.
Williams H; Jayaraman PS; Gaston K
J Mol Biol; 2008 Oct; 383(1):10-23. PubMed ID: 18755198
[TBL] [Abstract][Full Text] [Related]
4. The PRH/Hex repressor protein causes nuclear retention of Groucho/TLE co-repressors.
Desjobert C; Noy P; Swingler T; Williams H; Gaston K; Jayaraman PS
Biochem J; 2009 Jan; 417(1):121-32. PubMed ID: 18713067
[TBL] [Abstract][Full Text] [Related]
5. Purification and characterisation of the PRH homeodomain: Removal of the N-terminal domain of PRH increases the PRH homeodomain-DNA interaction.
Soufi A; Gaston K; Jayaraman PS
Int J Biol Macromol; 2006 Aug; 39(1-3):45-50. PubMed ID: 16494938
[TBL] [Abstract][Full Text] [Related]
6. CK2 phosphorylation of the PRH/Hex homeodomain functions as a reversible switch for DNA binding.
Soufi A; Noy P; Buckle M; Sawasdichai A; Gaston K; Jayaraman PS
Nucleic Acids Res; 2009 Jun; 37(10):3288-300. PubMed ID: 19324893
[TBL] [Abstract][Full Text] [Related]
7. DNA compaction by the higher-order assembly of PRH/Hex homeodomain protein oligomers.
Soufi A; Sawasdichai A; Shukla A; Noy P; Dafforn T; Smith C; Jayaraman PS; Gaston K
Nucleic Acids Res; 2010 Nov; 38(21):7513-25. PubMed ID: 20675722
[TBL] [Abstract][Full Text] [Related]
8. The proline-rich homeodomain protein recruits members of the Groucho/Transducin-like enhancer of split protein family to co-repress transcription in hematopoietic cells.
Swingler TE; Bess KL; Yao J; Stifani S; Jayaraman PS
J Biol Chem; 2004 Aug; 279(33):34938-47. PubMed ID: 15187083
[TBL] [Abstract][Full Text] [Related]
9. PRH represses transcription in hematopoietic cells by at least two independent mechanisms.
Guiral M; Bess K; Goodwin G; Jayaraman PS
J Biol Chem; 2001 Jan; 276(4):2961-70. PubMed ID: 11054411
[TBL] [Abstract][Full Text] [Related]
10. The transcriptional repressor protein PRH interacts with the proteasome.
Bess KL; Swingler TE; Rivett AJ; Gaston K; Jayaraman PS
Biochem J; 2003 Sep; 374(Pt 3):667-75. PubMed ID: 12826010
[TBL] [Abstract][Full Text] [Related]
11. Misregulation of the proline rich homeodomain (PRH/HHEX) protein in cancer cells and its consequences for tumour growth and invasion.
Gaston K; Tsitsilianos MA; Wadey K; Jayaraman PS
Cell Biosci; 2016; 6():12. PubMed ID: 26877867
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase CK2 inactivates PRH/Hhex using multiple mechanisms to de-repress VEGF-signalling genes and promote cell survival.
Noy P; Sawasdichai A; Jayaraman PS; Gaston K
Nucleic Acids Res; 2012 Oct; 40(18):9008-20. PubMed ID: 22844093
[TBL] [Abstract][Full Text] [Related]
13. The proline-rich homeodomain protein, PRH, is a tissue-specific inhibitor of eIF4E-dependent cyclin D1 mRNA transport and growth.
Topisirovic I; Culjkovic B; Cohen N; Perez JM; Skrabanek L; Borden KL
EMBO J; 2003 Feb; 22(3):689-703. PubMed ID: 12554669
[TBL] [Abstract][Full Text] [Related]
14. A mechanism of nucleocytoplasmic trafficking for the homeodomain protein PRH.
Ploski JE; Topisirovic I; Park KW; Borden KL; Radu A
Mol Cell Biochem; 2009 Dec; 332(1-2):173-81. PubMed ID: 19588232
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase CK2 inhibition suppresses neointima formation via a proline-rich homeodomain-dependent mechanism.
Wadey KS; Brown BA; Sala-Newby GB; Jayaraman PS; Gaston K; George SJ
Vascul Pharmacol; 2017 Dec; 99():34-44. PubMed ID: 28927755
[TBL] [Abstract][Full Text] [Related]
16. A Runaway PRH/HHEX-Notch3-Positive Feedback Loop Drives Cholangiocarcinoma and Determines Response to CDK4/6 Inhibition.
Kitchen P; Lee KY; Clark D; Lau N; Lertsuwan J; Sawasdichai A; Satayavivad J; Oltean S; Afford S; Gaston K; Jayaraman PS
Cancer Res; 2020 Feb; 80(4):757-770. PubMed ID: 31843982
[TBL] [Abstract][Full Text] [Related]
17. PRH/Hhex controls cell survival through coordinate transcriptional regulation of vascular endothelial growth factor signaling.
Noy P; Williams H; Sawasdichai A; Gaston K; Jayaraman PS
Mol Cell Biol; 2010 May; 30(9):2120-34. PubMed ID: 20176809
[TBL] [Abstract][Full Text] [Related]
18. Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression.
Stepanova V; Jayaraman PS; Zaitsev SV; Lebedeva T; Bdeir K; Kershaw R; Holman KR; Parfyonova YV; Semina EV; Beloglazova IB; Tkachuk VA; Cines DB
J Biol Chem; 2016 Jul; 291(29):15029-45. PubMed ID: 27151212
[TBL] [Abstract][Full Text] [Related]
19. The promyelocytic leukemia protein PML interacts with the proline-rich homeodomain protein PRH: a RING may link hematopoiesis and growth control.
Topcu Z; Mack DL; Hromas RA; Borden KL
Oncogene; 1999 Nov; 18(50):7091-100. PubMed ID: 10597310
[TBL] [Abstract][Full Text] [Related]
20. The homeodomain protein PRH influences the differentiation of haematopoietic cells.
Jayaraman PS; Frampton J; Goodwin G
Leuk Res; 2000 Dec; 24(12):1023-31. PubMed ID: 11077116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]